Whittier Trust Co. boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 165,646 shares of the pharmacy operator’s stock after buying an additional 3,178 shares during the period. Whittier Trust Co.’s holdings in CVS Health Corporation were worth $13,328,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Mercer Capital Advisers Inc. bought a new position in CVS Health Corporation during the first quarter valued at about $118,000. Gemmer Asset Management LLC raised its position in CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares in the last quarter. Orrstown Financial Services Inc. raised its position in CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock valued at $165,000 after buying an additional 2,000 shares in the last quarter. SRS Capital Advisors Inc. raised its position in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares in the last quarter. Finally, Edmp Inc. bought a new position in CVS Health Corporation during the first quarter valued at about $202,000. Hedge funds and other institutional investors own 81.92% of the company’s stock.

CVS Health Corporation (NYSE CVS) traded up 0.34% during mid-day trading on Friday, hitting $79.41. The company’s stock had a trading volume of 2,985,502 shares. The firm has a market cap of $80.73 billion, a price-to-earnings ratio of 15.82 and a beta of 0.91. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $98.44. The firm has a 50 day moving average of $78.83 and a 200-day moving average of $78.96.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The company had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same quarter in the prior year, the business posted $1.32 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. On average, equities research analysts expect that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were issued a $0.50 dividend. The ex-dividend date was Thursday, July 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. CVS Health Corporation’s dividend payout ratio is presently 39.92%.

WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/whittier-trust-co-purchases-3178-shares-of-cvs-health-corporation-nysecvs/1479703.html.

Several research analysts have recently issued reports on CVS shares. Tigress Financial started coverage on CVS Health Corporation in a research report on Thursday, April 27th. They issued a “buy” rating on the stock. Vetr lowered CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price target on the stock. in a research report on Thursday, April 27th. Evercore ISI restated an “outperform” rating and issued a $88.00 price target (up from $87.00) on shares of CVS Health Corporation in a research report on Wednesday, May 3rd. ValuEngine lowered CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Jefferies Group LLC restated a “hold” rating and issued a $82.00 price target on shares of CVS Health Corporation in a research report on Friday, June 9th. Eight analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $91.27.

In related news, EVP Helena Foulkes sold 20,333 shares of the company’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $80.00, for a total value of $1,626,640.00. Following the sale, the executive vice president now owns 59,301 shares in the company, valued at approximately $4,744,080. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David M. Denton sold 230,510 shares of the company’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the sale, the chief financial officer now owns 176,983 shares in the company, valued at approximately $14,158,640. The disclosure for this sale can be found here. Insiders sold a total of 271,175 shares of company stock worth $21,632,597 in the last 90 days. 0.61% of the stock is currently owned by company insiders.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.